This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Grant Agreement No. 956851.

Alen Damiani

My name is Alen Damiani, I am an Italian-Croatian aspiring scientist. 

I’m graduated in Pharmaceutical Chemistry and Technologies (single-cycle master’s degree) at the University of Trieste in Italy.  My studies introduced me to the different phases of drug development, among which pharmaceutical technology piqued my particular interest. As a result of this, at the end of my studies, I carried out my dissertation, in the Prof. João Pinto research group at the University of Lisbon, where I worked in the field of production and physical-chemical characterization of binary API systems obtained by mechanochemistry. And it was here that I really learned how much there was still to learn. 
I started my working career as a R&D Assistant Scientist at PharmaHemp, a young and fast growing company from Ljubljana in Slovenia. There, for almost two years, I was dealing with the chemistry of phytocannabinoids, developing innovative purification processes and formulations with aim to enhance their bioavailability. 
After these experiences, following my great interest in pharmaceutical technology, I started my PhD at KU Leuven, in Drug Delivery and Disposition research unit, under the supervision of Prof. Van den Mooter. Now, in academia the passion for science remains with me. There’s certainly yet more to learn, yet more problems to solve, and yet more to build. And for this, I am very grateful.